Hca Healthcare, Inc. HCA
We take great care to ensure that the data presented and summarized in this overview for HCA Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HCA
View all-
Vanguard Group Inc Valley Forge, PA15.8MShares$6.14 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY14.9MShares$5.79 Billion0.11% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL11.6MShares$4.5 Billion6.0% of portfolio
-
State Street Corp Boston, MA8.15MShares$3.17 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA5.24MShares$2.04 Billion0.36% of portfolio
-
First Eagle Investment Management, LLC4.52MShares$1.76 Billion3.29% of portfolio
-
Geode Capital Management, LLC Boston, MA3.89MShares$1.52 Billion0.11% of portfolio
-
Jpmorgan Chase & CO New York, NY3.6MShares$1.4 Billion0.1% of portfolio
-
Capital World Investors Los Angeles, CA3.38MShares$1.32 Billion0.2% of portfolio
-
Bank Of America Corp Charlotte, NC3.28MShares$1.28 Billion0.09% of portfolio
Latest Institutional Activity in HCA
Top Purchases
Top Sells
About HCA
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Insider Transactions at HCA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 13
2025
|
Samuel N Hazen CEO |
BUY
Bona fide gift
|
Indirect |
90,076
+49.18%
|
-
|
May 13
2025
|
Samuel N Hazen CEO |
SELL
Bona fide gift
|
Indirect |
90,076
-100.0%
|
-
|
May 13
2025
|
Jon M Foster EVP and COO |
BUY
Other acquisition or disposition
|
Indirect |
15,925
+18.05%
|
$5,844,475
$367.19 P/Share
|
May 13
2025
|
Jon M Foster EVP and COO |
SELL
Other acquisition or disposition
|
Indirect |
15,925
-100.0%
|
$5,844,475
$367.19 P/Share
|
May 13
2025
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
3,155
+2.56%
|
-
|
May 13
2025
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Indirect |
2,075
-11.53%
|
-
|
May 13
2025
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Direct |
1,080
-8.54%
|
-
|
May 13
2025
|
Jon M Foster EVP and COO |
SELL
Open market or private sale
|
Direct |
15,698
-55.38%
|
$5,792,562
$369.32 P/Share
|
May 07
2025
|
Mike A Marks EVP and CFO |
SELL
Bona fide gift
|
Direct |
144
-100.0%
|
-
|
May 07
2025
|
Mike A Marks EVP and CFO |
BUY
Other acquisition or disposition
|
Indirect |
285
+0.65%
|
$101,460
$356.84 P/Share
|
May 07
2025
|
Mike A Marks EVP and CFO |
SELL
Other acquisition or disposition
|
Indirect |
285
-100.0%
|
$101,460
$356.84 P/Share
|
May 07
2025
|
Mike A Marks EVP and CFO |
BUY
Bona fide gift
|
Indirect |
181
+0.42%
|
-
|
May 07
2025
|
Mike A Marks EVP and CFO |
SELL
Bona fide gift
|
Indirect |
181
-38.84%
|
-
|
May 06
2025
|
Mike A Marks EVP and CFO |
SELL
Bona fide gift
|
Direct |
610
-75.0%
|
-
|
May 06
2025
|
Mike A Marks EVP and CFO |
BUY
Other acquisition or disposition
|
Direct |
288
+50.0%
|
$101,664
$353.57 P/Share
|
May 06
2025
|
Mike A Marks EVP and CFO |
SELL
Other acquisition or disposition
|
Indirect |
288
-0.67%
|
$101,664
$353.57 P/Share
|
May 06
2025
|
Mike A Marks EVP and CFO |
BUY
Bona fide gift
|
Indirect |
466
+50.0%
|
-
|
Apr 30
2025
|
William R Frist |
BUY
Other acquisition or disposition
|
Indirect |
10,504
+0.66%
|
$3,571,360
$340.6 P/Share
|
Apr 29
2025
|
William R Frist |
BUY
Grant, award, or other acquisition
|
Direct |
1,026
+7.35%
|
-
|
Apr 29
2025
|
Thomas F Frist Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,320
+8.18%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 31.8K shares |
---|---|
Other acquisition or disposition | 1.06M shares |
Exercise of conversion of derivative security | 128K shares |
Bona fide gift | 159K shares |
Other acquisition or disposition | 1.05M shares |
---|---|
Payment of exercise price or tax liability | 81.1K shares |
Open market or private sale | 55.9K shares |
Bona fide gift | 159K shares |